Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN.
Döhner H, Wei AH, Appelbaum FR, Craddock C, DiNardo CD, Dombret H, Ebert BL, Fenaux P, Godley LA, Hasserjian RP, Larson RA, Levine RL, Miyazaki Y, Niederwieser D, Ossenkoppele G, Röllig C, Sierra J, Stein EM, Tallman MS, Tien HF, Wang J, Wierzbowska A, Löwenberg B. Döhner H, et al. Among authors: sierra j. Blood. 2022 Sep 22;140(12):1345-1377. doi: 10.1182/blood.2022016867. Blood. 2022. PMID: 35797463 Free article.
Survival improvement of patients with FLT3 mutated acute myeloid leukemia: results from a prospective 9 years cohort.
Oñate G, Pratcorona M, Garrido A, Artigas-Baleri A, Bataller A, Tormo M, Arnan M, Vives S, Coll R, Salamero O, Vall-Llovera F, Sampol A, Garcia A, Cervera M, Avila SG, Bargay J, Ortín X, Nomdedéu JF, Esteve J, Sierra J; Spanish Cooperative Group for the Study and Treatment of Acute Leukemias and Myelodysplasias (CETLAM). Oñate G, et al. Among authors: sierra j. Blood Cancer J. 2023 May 5;13(1):69. doi: 10.1038/s41408-023-00839-1. Blood Cancer J. 2023. PMID: 37147301 Free PMC article.
Unrelated donor transplants in adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission.
Marks DI, Pérez WS, He W, Zhang MJ, Bishop MR, Bolwell BJ, Bredeson CN, Copelan EA, Gale RP, Gupta V, Hale GA, Isola LM, Jakubowski AA, Keating A, Klumpp TR, Lazarus HM, Liesveld JL, Maziarz RT, McCarthy PL, Sabloff M, Schiller G, Sierra J, Tallman MS, Waller EK, Wiernik PH, Weisdorf DJ. Marks DI, et al. Among authors: sierra j. Blood. 2008 Jul 15;112(2):426-34. doi: 10.1182/blood-2007-12-128918. Epub 2008 Apr 8. Blood. 2008. PMID: 18398065 Free PMC article.
Long-term outcomes in patients with relapsed/refractory acute myeloid leukemia and other high-risk myeloid malignancies after undergoing sequential conditioning regimen based on IDA-FLAG and high-dose melphalan.
Guijarro F, Bataller A, Diaz-Beyá M, Garrido A, Coll-Ferrà C, Vives S, Salamero O, Valcárcel D, Tormo M, Arnan M, Sampol A, Castaño-Díez S, Martínez C, Suárez-Lledó M, Fernández-Avilés F, Hernández-Boluda JC, Ribera JM, Rovira M, Brunet S, Sierra J, Esteve J. Guijarro F, et al. Among authors: sierra j. Bone Marrow Transplant. 2022 Aug;57(8):1304-1312. doi: 10.1038/s41409-022-01703-9. Epub 2022 May 28. Bone Marrow Transplant. 2022. PMID: 35643942
The impact of GVHD on outcomes after adult single cord blood transplantation in European and Japanese populations.
Kanda J, Hayashi H, Ruggeri A, Kimura F, Volt F, Takahashi S, Kako S, Tozatto-Maio K, Yanada M, Sanz G, Uchida N, Angelucci E, Kato S, Mohty M, Forcade E, Tanaka M, Sierra J, Ohta T, Saccardi R, Fukuda T, Ichinohe T, Kimura T, Rocha V, Okamoto S, Nagler A, Atsuta Y, Gluckman E. Kanda J, et al. Among authors: sierra j. Bone Marrow Transplant. 2022 Jan;57(1):57-64. doi: 10.1038/s41409-021-01479-4. Epub 2021 Oct 11. Bone Marrow Transplant. 2022. PMID: 34635798 Free article.
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP.
Onida F, Sbianchi G, Radujkovic A, Sockel K, Kröger N, Sierra J, Socié G, Cornelissen J, Poiré X, Raida L, Bourhis JH, Finke J, Passweg J, Salmenniemi U, Schouten HC, Beguin Y, Martin S, Deconinck E, Ganser A, Zver S, Lioure B, Rohini R, Koster L, Hayden P, Iacobelli S, Robin M, Yakoub-Agha I. Onida F, et al. Among authors: sierra j. Bone Marrow Transplant. 2022 Jun;57(6):896-902. doi: 10.1038/s41409-021-01555-9. Epub 2022 Mar 29. Bone Marrow Transplant. 2022. PMID: 35352038 Free article.
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.
Schlenk RF, Pasquini MC, Pérez WS, Zhang MJ, Krauter J, Antin JH, Bashey A, Bolwell BJ, Büchner T, Cahn JY, Cairo MS, Copelan EA, Cutler CS, Döhner H, Gale RP, Ilhan O, Lazarus HM, Liesveld JL, Litzow MR, Marks DI, Maziarz RT, McCarthy PL, Nimer SD, Sierra J, Tallman MS, Weisdorf DJ, Horowitz MM, Ganser A; CIBMTR Acute Leukemia Working Committee. Schlenk RF, et al. Among authors: sierra j. Biol Blood Marrow Transplant. 2008 Feb;14(2):187-96. doi: 10.1016/j.bbmt.2007.10.006. Epub 2007 Dec 20. Biol Blood Marrow Transplant. 2008. PMID: 18215779 Free PMC article.
Predictors of return to work after autologous stem cell transplantation in patients with multiple myeloma.
Granell M, Senín A, Barata A, Cibeira MT, Gironella M, López-Pardo J, Motlló C, Garcia-Guiñón A, Ben-Azaiz R, Abella E, Soler A, Canet M, Martí JM, Martino R, Sierra J, de Larrea CF, Oriol A, Rosiñol L; Group for the Study of Myeloma and Amyloidosis of Catalonia (GEMMAC). Granell M, et al. Among authors: sierra j. Bone Marrow Transplant. 2021 Dec;56(12):2904-2910. doi: 10.1038/s41409-021-01429-0. Epub 2021 Aug 17. Bone Marrow Transplant. 2021. PMID: 34404917
1,134 results